- Filed
- May 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 13, 2024 | 1.08K sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $251.96M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $1.28B |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $530.65M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $1.61B |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $442.98M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $741.91M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $3.1B |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $3.52B |
| Current Assets | Q1 2024 · Mar 31, 2024 | $710.25M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $2.14B |
| Total Assets | Q1 2024 · Mar 31, 2024 | $3.69B |
| Total Assets | Q1 2024 · Dec 31, 2023 | $5.2B |
| Capex | Q1 2024 · Mar 31, 2023 | $47.03M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $48.79M |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $112.36M |
| Operating Income | Q1 2024 · Mar 31, 2023 | $43.41M |
| Revenue | Q1 2024 · Mar 31, 2023 | $437.82M |